Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: Relevance to Parkinson disease

Human Molecular Genetics

Volumn 25, Issue 16, 2016, Pages 3432-3445

  Magalhaes, Joana ^a   Gegg, Matthew E ^a   Migdalska Richards, Anna ^a   Doherty, Mary K ^b   Whitfield, Phillip D ^b   Schapira, Anthony H V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; AMYLOID BETA PROTEIN[1-42]; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; CERAMIDE; CHOLESTEROL; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK COGNATE PROTEIN 70; HUNTINGTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN; RAB7 PROTEIN; S6 KINASE; SEQUESTOSOME 1; SPHINGOMYELIN; RAB PROTEIN; SNCA PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; AUTOLYSOSOME; AUTOPHAGY LYSOSOMAL REFORMATION; CELL PROLIFERATION; CELL STRUCTURE; CHAPERONE-MEDIATED AUTOPHAGY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; ENDOSOME; ENZYME PHOSPHORYLATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; LYSOSOME; MACROAUTOPHAGY; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKIN FIBROBLAST; ANIMAL; AUTOPHAGY; BRAIN; FIBROBLAST; GAUCHER DISEASE; GENETICS; METABOLISM; MUTATION; NERVE CELL; PATHOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; AUTOPHAGY; BRAIN; FIBROBLASTS; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; LYSOSOMES; MICE; MUTATION; NEURONS; PARKINSON DISEASE; RAB GTP-BINDING PROTEINS;

EID: 84994143522     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw185     Document Type: Article

References (52)

1. Grabowski, G.A. (2008) Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet, 372, 1263-1271.
2. Beutler, E., G.G. (2001), In Gaucher Disease. McGraw-Hill, New York, Vol. The Metabolic and Molecular Basis of Inherited Disease, pp. 3635-3668.
3. Schapira, A.H. and Jenner, P. (2011) Etiology and pathogenesis of Parkinson's disease. Mov. Dis., 26, 1049-1055.
4. Aharon-Peretz, J., Rosenbaum, H. and Gershoni-Baruch, R. (2004) Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Eng. J. Med., 351, 1972-1977.
5. Westbroek, W., Gustafson, A.M. and Sidransky, E. (2011) Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol. Med., 17, 485-493.
6. Wong, K., Sidransky, E., Verma, A., Mixon, T., Sandberg, G.D., Wakefield, L.K., Morrison, A., Lwin, A., Colegial, C., Allman, J.M., et al. (2004) Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol. Genet. Metab., 82, 192-207.
7. Sidransky, E., Nalls, M.A., Aasly, J.O., Aharon-Peretz, J., Annesi, G., Barbosa, E.R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Eng. J. Med., 361, 1651-1661.
8. Neumann, J., Bras, J., Deas, E., O'Sullivan, S.S., Parkkinen, L., Lachmann, R.H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain, 132, 1783-1794.
9. Siebert, M., Sidransky, E. and Westbroek, W. (2014) Glucocerebrosidase is shaking up the synucleinopathies. Brain, 137, 1304-1322.
10. Brockmann, K., Srulijes, K., Hauser, A.K., Schulte, C., Csoti, I., Gasser, T. and Berg, D. (2011) GBA-associated PD presents with nonmotor characteristics. Neurology, 77, 276-280.
11. Gegg, M.E., Burke, D., Heales, S.J., Cooper, J.M., Hardy, J., Wood, N.W. and Schapira, A.H. (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann. Neurol., 72, 455-463.
12. Murphy, K.E., Gysbers, A.M., Abbott, S.K., Tayebi, N., Kim, W.S., Sidransky, E., Cooper, A., Garner, B. and Halliday, G.M. (2014) Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain, 137, 834-848.
13. Rocha, E.M., Smith, G.A., Park, E., Cao, H., Brown, E., Hallett, P. and Isacson, O. (2015) Progressive decline of glucocerebrosidase in aging and Parkinson's disease. Ann. Clin. Transl. Neurol., 2, 433-438.
14. Sardi, S.P., Clarke, J., Kinnecom, C., Tamsett, T.J., Li, L., Stanek, L.M., Passini, M.A., Grabowski, G.A., Schlossmacher, M.G., Sidman, R.L., et al. (2011) CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc. Natl Acad. Sci. USA, 108, 12101-12106.
15. Schondorf, D.C., Aureli, M., McAllister, F.E., Hindley, C.J., Mayer, F., Schmid, B., Sardi, S.P., Valsecchi, M., Hoffmann, S., Schwarz, L.K., et al. (2014) iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calciumhomeostasis. Nat. Commun., 5, 4028.
16. Cullen, V., Sardi, S.P., Ng, J., Xu, Y.H., Sun, Y., Tomlinson, J.J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alphasynuclein processing. Ann. Neurol., 69, 940-953.
17. Mazzulli, J.R., Xu, Y.H., Sun, Y., Knight, A.L., McLean, P.J., Caldwell, G.A., Sidransky, E., Grabowski, G.A. and Krainc, D. (2011) Gaucher disease glucocerebrosidase and alphasynuclein form a bidirectional pathogenic loop in synucleinopathies. Cell, 146, 37-52.
18. Cleeter, M.W., Chau, K.Y., Gluck, C., Mehta, A., Hughes, D.A., Duchen, M., Wood, N.W., Hardy, J., Mark Cooper, J. and Schapira, A.H. (2013) Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage. Neurochem Int., 62, 1-7.
19. Osellame, L.D., Rahim, A.A., Hargreaves, I.P., Gegg, M.E., Richard-Londt, A., Brandner, S., Waddington, S.N., Schapira, A.H. and Duchen, M.R. (2013) Mitochondria and quality control defects in a mouse model of Gaucher disease-links to Parkinson's disease. Cell Metab., 17, 941-953.
20. Dehay, B., Martinez-Vicente, M., Caldwell, G.A., Caldwell, K.A., Yue, Z., Cookson, M.R., Klein, C., Vila, M. and Bezard, E. (2013) Lysosomal impairment in Parkinson's disease. Mov.Disord., 28, 725-732.
21. Pan, T., Kondo, S., Le, W. and Jankovic, J. (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain, 131, 1969-1978.
22. Alvarez-Erviti, L., Rodriguez-Oroz, M.C., Cooper, J.M., Caballero, C., Ferrer, I., Obeso, J.A. and Schapira, A.H. (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol., 67, 1464-1472.
23. Nixon, R.A. (2013) The role of autophagy in neurodegenerative disease. Nature Medicine, 19, 983-997.
24. Saftig, P. and Klumperman, J. (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol., 10, 623-635.
25. Yu, L., McPhee, C.K., Zheng, L., Mardones, G.A., Rong, Y., Peng, J., Mi, N., Zhao, Y., Liu, Z., Wan, F., et al. (2010) Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature, 465, 942-946.
26. Enquist, I.B., Lo Bianco, C., Ooka, A., Nilsson, E., Mansson, J.E., Ehinger, M., Richter, J., Brady, R.O., Kirik, D. and Karlsson, S. (2007) Murine models of acute neuronopathic Gaucher disease. Proc. Natl. Acad. Sci. USA, 104, 17483-17488.
27. Jager, S., Bucci, C., Tanida, I., Ueno, T., Kominami, E., Saftig, P. and Eskelinen, E.L. (2004) Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci., 117, 4837-4848.
28. Takahashi, Y., Nada, S., Mori, S., Soma-Nagae, T., Oneyama, C. and Okada, M. (2012) The late endosome/lysosomeanchored p18-mTORC1 pathway controls terminal maturation of lysosomes. Biochem. Biophys.Res. Commun., 417, 1151-1157.
29. Fernandes, H.J.R., Hartfield, E.M., Christian, H.C., Emmanoulidou, E., Zheng, Y., Booth, H., Bogetofte, H., Lang, C., Ryan, B.J., Sardi, S.P., et al. (2016) ER Stress and Autophagic Perturbations Lead to Elevated Extracellular a-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons. Stem Cell Reports, 6, 342-356.
30. Awad, O., Sarkar, C., Panicker, L.M., Miller, D., Zeng, X., Sgambato, J.A., Lipinski, M.M. and Feldman, R.A. (2015) Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells. Hum. Mol. Genet., 24, 5775-5788.
31. Rink, J., Ghigo, E., Kalaidzidis, Y. and Zerial, M. (2005) Rab conversion as a mechanism of progression from early to late endosomes. Cell, 122, 735-749.
32. Rong, Y., McPhee, C.K., Deng, S., Huang, L., Chen, L., Liu, M., Tracy, K., Baehrecke, E.H., Yu, L. and Lenardo, M.J. (2011) Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation. Proc. Natl. Acad. Sci. U S A, 108, 7826-7831.
33. Bissig, C. and Gruenberg, J. (2013) Lipid sorting and multivesicular endosome biogenesis. Cold Spring Harb Perspect Biol., 5, a016816.
34. MacLeod, D.A., Rhinn, H., Kuwahara, T., Zolin, A., Di Paolo, G., McCabe, B.D., Marder, K.S., Honig, L.S., Clark, L.N., Small, S.A., et al. (2013) RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron, 77, 425-439.
35. Gomez-Suaga, P., Rivero-Rios, P., Fdez, E., Blanca Ramirez, M., Ferrer, I., Aiastui, A., Lopez De Munain, A. and Hilfiker, S. (2014) LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum. Mol. Genet., 23, 6779-6796.
36. Hockey, L.N., Kilpatrick, B.S., Eden, E.R., Lin-Moshier, Y., Brailoiu, G.C., Brailoiu, E., Futter, C.E., Schapira, A.H., Marchant, J.S. and Patel, S. (2015) Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition. J. Cell Sci., 128, 232-238.
37. Sillence, D.J., Puri, V., Marks, D.L., Butters, T.D., Dwek, R.A., Pagano, R.E. and Platt, F.M. (2002) Glucosylceramide modulates membrane traffic along the endocytic pathway. J. Lipid Res., 43, 1837-1845.
38. Tatti, M., Motta, M., Di Bartolomeo, S., Scarpa, S., Cianfanelli, V., Cecconi, F. and Salvioli, R. (2012) Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts. Hum. Mol. Genet., 21, 5159-5173.
39. Sillence, D.J. (2013) Glucosylceramide modulates endolysosomal pH in Gaucher disease. Mol. Genet. Metab., 109, 194-200.
40. Ron, I. and Horowitz, M. (2008) Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients. Mol. Genet. Metabol., 93, 426-436.
41. Salvioli, R., Tatti, M., Scarpa, S., Moavero, S.M., Ciaffoni, F., Felicetti, F., Kaneski, C.R., Brady, R.O. and Vaccaro, A.M. (2005) The N370S (Asn370→Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C. Biochem J, 390, 95-103.
42. Mann, D., Reynolds, K., Smith, D. and Muntner, P. (2008) Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann. Pharmacother., 42, 1208-1215.
43. Lin, C.H., Lin, H.I., Chen, M.L., Lai, T.T., Cao, L.P., Farrer, M.J., Wu, R.M. and Chien, C.T. (2016) Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3beta activity. Hum. Mol. Genet., pii: ddw068.
44. Alvarez-Erviti, L., Seow, Y., Schapira, A.H., Gardiner, C., Sargent, I.L., Wood, M.J. and Cooper, J.M. (2011) Lysosomal dysfunction increases exosome-mediated alphasynuclein release and transmission. Neurobiol. Dis., 42, 360-367.
45. Guo, J.L. and Lee, V.M. (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med., 20, 130-138.
46. Pacheco, C.D. and Lieberman, A.P. (2007) Lipid trafficking defects increase Beclin-1 and activate autophagy in Niemann-Pick type C disease. Autophagy, 3, 487-489.
47. Schapira, A.H. (2015) Glucocerebrosidase and Parkinson disease: Recent advances. Mol. Cell. Neurosci., 66(Pt A):37-42.
48. McNeill, A., Magalhaes, J., Shen, C., Chau, K.Y., Hughes, D., Mehta, A., Foltynie, T., Cooper, J.M., Abramov, A.Y., Gegg, M., et al. (2014) Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain, 137, 1481-1495.
49. Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S. and Campisi, J. (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol., 5, 741-747.
50. Wendeler, M. and Sandhoff, K. (2009) Hexosaminidase assays. Glycoconj J., 26, 945-952.
51. Storrie, B. and Madden, E.A. (1990) Isolation of subcellular organelles. Methods in Enzymol., 182, 203-225.
52. Bolte, S. and Cordelieres, F.P. (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc., 224, 213-232.